SEC Form 4 · accession 0001193125-26-289278
AGENUS INC · AGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Garo H Armen
Officer — See Remarks · Director
Period of report
Jun 26, 2026
Accepted (ET)
Jun 30, 2026 · 6:06 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001098972
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 26, 2026 | A | 5,364 | $3.03 | A | 366,256 | D | |
| Common StockF3 | holding | — | — | — | 31,298 | I | See Footnote | |
| Common StockF4 | holding | — | — | — | 28,950 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending June 26th, 2026. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.
- F2$3.03 is the closing price of our Common Stock on June 26th, 2026, the last trading day for the payroll date for the pay period ending June 26th, 2026.
- F3Shares are held in Dr. Armen's IRA accounts.
- F4Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 5,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.
Remarks
Chairman, Chief Executive Officer and Principal Financial Officer